Osaka, Japan

Yasuki Niwa

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yasuki Niwa: Innovator in Pharmaceutical Development

Introduction

Yasuki Niwa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. With a total of six patents to his name, Niwa's work is recognized for its innovative approach to drug development.

Latest Patents

One of Yasuki Niwa's latest patents involves a sulfonamide or sulfinamide compound that induces BRD4 protein degradation. This compound is noted for its potential as a therapeutic agent for cancer. The patent details a compound or a pharmaceutically acceptable salt that demonstrates superior action in inducing the degradation of BRD4 protein, which is crucial in cancer therapy.

Career Highlights

Throughout his career, Yasuki Niwa has worked with notable companies in the pharmaceutical industry, including Mitsubishi Tanabe Pharma Corporation and AstraZeneca. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Yasuki Niwa has collaborated with several talented individuals in his field, including Kiyomi Ohba and Maiko Hamada. These collaborations have fostered a creative environment that has led to the development of groundbreaking pharmaceutical solutions.

Conclusion

Yasuki Niwa's contributions to pharmaceutical innovation, particularly in cancer treatment, highlight his role as a leading inventor in the industry. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…